Full-Dose Antithrombotic Aids Selected COVID-19 ICU Patients
Compared with reduced-dose prophylaxis, full-dose anticoagulation cut thrombotic events but also boosted bleeding in patients with COVID-19 who needed ICU admission.
Source: medscape.com
Stay updated with breaking news from Davidd Berg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Compared with reduced-dose prophylaxis, full-dose anticoagulation cut thrombotic events but also boosted bleeding in patients with COVID-19 who needed ICU admission.
With an essential role established for SGLT2 inhibitors for patients with progressive renal dysfunction or heart failure, researchers discuss how best to use these agents in those with type 2 diabetes.